6:06

Treatment Options for Patients Not Eligible for the EV/Pembrolizumab Regimen

4:54

Molecular Biomarkers and Risk Stratification in High-Risk Non-Muscle Invasive Bladder Cancer

4:52

Looking Ahead: TAR-200's Evolving Role in NMIBC and Future Directions in Bladder Cancer Care

14:38

Palbociclib (IBRANCE) Revs Up Metastatic Breast Cancer in PATINA Results - SABCS - Otto Metzger, MD

9:18

PENELOPE: TAR-200 Shows Deeper Tissue Penetration vs Standard Intravesical Therapy

9:15

Patient Characteristics to Consider for Doublet, Triplet Therapy in mHSPC and mCRPC

24:36

Nate Ward, M.S. -- Treating Cancer with Metabolic Agents

1:08:45

Progressive Multifocal Leukoencephalopathy: Diagnosis & Advances in Treatment by Anita Fletcher, MD